Caitong International Asset Management Co., LTD Biomarin Pharmaceutical Inc Transaction History
Caitong International Asset Management Co., LTD
- $144 Billion
- Q3 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 737 shares of BMRN stock, worth $40,336. This represents 0.03% of its overall portfolio holdings.
Number of Shares
737Holding current value
$40,336% of portfolio
0.03%Shares
2 transactions
Others Institutions Holding BMRN
# of Institutions
669Shares Held
182MCall Options Held
1.52MPut Options Held
1.01M-
Black Rock Inc. New York, NY22.7MShares$1.24 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.6MShares$1.02 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.2MShares$833 Million0.65% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$804 Million0.46% of portfolio
-
State Street Corp Boston, MA8.76MShares$480 Million0.02% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...